Terms: = Ovarian cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1
25 results:
1. Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
Kasikova L; Rakova J; Hensler M; Lanickova T; Tomankova J; Pasulka J; Drozenova J; Mojzisova K; Fialova A; Vosahlikova S; Laco J; Ryska A; Dundr P; Kocian R; Brtnicky T; Skapa P; Capkova L; Kovar M; Prochazka J; Praznovec I; Koblizek V; Taskova A; Tanaka H; Lischke R; Mendez FC; Vachtenheim J; Heinzelmann-Schwarz V; Jacob F; McNeish IA; Halaska MJ; Rob L; Cibula D; Orsulic S; Galluzzi L; Spisek R; Fucikova J
Nat Commun; 2024 Mar; 15(1):2528. PubMed ID: 38514660
[TBL] [Abstract] [Full Text] [Related]
2. BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control.
McGray AJR; Chiello JL; Tsuji T; Long M; Maraszek K; Gaulin N; Rosario SR; Hess SM; Abrams SI; Kozbor D; Odunsi K; Zsiros E
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37647218
[TBL] [Abstract] [Full Text] [Related]
3. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis.
Sun Z; Bai C; Su M; Tang H; Wu X; Wang Y; Bao H; Liu X; Wu X; Shao Y; Xu B
Mol Oncol; 2023 Sep; 17(9):1917-1929. PubMed ID: 37013911
[TBL] [Abstract] [Full Text] [Related]
5. Tissue residency of memory CD8
Tsuji T; Matsuzaki J; Odunsi K
Cancer Cell; 2022 May; 40(5):452-454. PubMed ID: 35537410
[TBL] [Abstract] [Full Text] [Related]
6. ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells.
Anadon CM; Yu X; Hänggi K; Biswas S; Chaurio RA; Martin A; Payne KK; Mandal G; Innamarato P; Harro CM; Mine JA; Sprenger KB; Cortina C; Powers JJ; Costich TL; Perez BA; Gatenbee CD; Prabhakaran S; Marchion D; Heemskerk MHM; Curiel TJ; Anderson AR; Wenham RM; Rodriguez PC; Conejo-Garcia JR
Cancer Cell; 2022 May; 40(5):545-557.e13. PubMed ID: 35427494
[TBL] [Abstract] [Full Text] [Related]
7. Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade.
Soovares P; Pasanen A; Similä-Maarala J; Bützow R; Lassus H
Gynecol Oncol; 2022 Jan; 164(1):187-194. PubMed ID: 34711431
[TBL] [Abstract] [Full Text] [Related]
8. Hepatocyte nuclear factor 1 beta: A perspective in cancer.
Chandra S; Srinivasan S; Batra J
Cancer Med; 2021 Mar; 10(5):1791-1804. PubMed ID: 33580750
[TBL] [Abstract] [Full Text] [Related]
9. Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
Lupini L; Scutiero G; Iannone P; Martinello R; Bassi C; Ravaioli N; Soave I; Bonaccorsi G; Lanza G; Gafà R; Loizzi V; Negrini M; Greco P
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13137. PubMed ID: 31412428
[TBL] [Abstract] [Full Text] [Related]
10. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA-214 Suppresses ovarian cancer by Targeting β-Catenin.
Liu Y; Lin J; Zhai S; Sun C; Xu C; Zhou H; Liu H
Cell Physiol Biochem; 2018; 45(4):1654-1662. PubMed ID: 29486472
[TBL] [Abstract] [Full Text] [Related]
12. Applying Precision Medicine to ovarian cancer: Proof-of-Principle for a "Molecular Second Look".
Schwartz M; Camacho-Vanegas O; Wood AM; Dashkoff M; Whitelock C; Harkins TT; Cohen CJ; Beddoe AM; Dottino P; Martignetti JA
Int J Gynecol Cancer; 2018 Mar; 28(3):479-485. PubMed ID: 29324546
[TBL] [Abstract] [Full Text] [Related]
13. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells.
Nogales FF; Prat J; Schuldt M; Cruz-Viruel N; Kaur B; D'Angelo E; Matias-Guiu X; Vidal A; McCluggage WG; Oosterhuis JW
Histopathology; 2018 Mar; 72(4):634-647. PubMed ID: 29106744
[TBL] [Abstract] [Full Text] [Related]
14. NFκB Promotes ovarian Tumorigenesis via Classical Pathways That Support Proliferative cancer Cells and Alternative Pathways That Support ALDH
House CD; Jordan E; Hernandez L; Ozaki M; James JM; Kim M; Kruhlak MJ; Batchelor E; Elloumi F; Cam MC; Annunziata CM
Cancer Res; 2017 Dec; 77(24):6927-6940. PubMed ID: 29074539
[TBL] [Abstract] [Full Text] [Related]
15. Knockdown of Tripartite Motif Containing 28 suppresses the migration, invasion and epithelial-mesenchymal transition in ovarian carcinoma cells through down-regulation of Wnt/β-catenin signaling pathway.
Deng B; Zhang S; Zhang Y; Miao Y; Meng X; Guo K
Neoplasma; 2017; 64(6):893-900. PubMed ID: 28895414
[TBL] [Abstract] [Full Text] [Related]
16. Downregulation of hnf1 homeobox B is associated with drug resistance in ovarian cancer.
Li J; Zhang Y; Gao Y; Cui Y; Liu H; Li M; Tian Y
Oncol Rep; 2014 Sep; 32(3):979-88. PubMed ID: 24968817
[TBL] [Abstract] [Full Text] [Related]
17. Epigenetic determinants of ovarian clear cell carcinoma biology.
Yamaguchi K; Huang Z; Matsumura N; Mandai M; Okamoto T; Baba T; Konishi I; Berchuck A; Murphy SK
Int J Cancer; 2014 Aug; 135(3):585-97. PubMed ID: 24382740
[TBL] [Abstract] [Full Text] [Related]
18. Integrative bioinformatics links hnf1B with clear cell carcinoma and tumor-associated thrombosis.
Cuff J; Salari K; Clarke N; Esheba GE; Forster AD; Huang S; West RB; Higgins JP; Longacre TA; Pollack JR
PLoS One; 2013; 8(9):e74562. PubMed ID: 24040285
[TBL] [Abstract] [Full Text] [Related]
19. Mutations in BRIP1 confer high risk of ovarian cancer.
Rafnar T; Gudbjartsson DF; Sulem P; Jonasdottir A; Sigurdsson A; Jonasdottir A; Besenbacher S; Lundin P; Stacey SN; Gudmundsson J; Magnusson OT; le Roux L; Orlygsdottir G; Helgadottir HT; Johannsdottir H; Gylfason A; Tryggvadottir L; Jonasson JG; de Juan A; Ortega E; Ramon-Cajal JM; García-Prats MD; Mayordomo C; Panadero A; Rivera F; Aben KK; van Altena AM; Massuger LF; Aavikko M; Kujala PM; Staff S; Aaltonen LA; Olafsdottir K; Bjornsson J; Kong A; Salvarsdottir A; Saemundsson H; Olafsson K; Benediktsdottir KR; Gulcher J; Masson G; Kiemeney LA; Mayordomo JI; Thorsteinsdottir U; Stefansson K
Nat Genet; 2011 Oct; 43(11):1104-7. PubMed ID: 21964575
[TBL] [Abstract] [Full Text] [Related]
20. ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
[TBL] [Abstract] [Full Text] [Related]
[Next]
